T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 205-217

  Perri, Anna ^a   Catalano, Stefania ^a   Bonofiglio, Daniela ^a   Vizza, Donatella ^a   Rovito, Daniela ^a   Qi, Hongyan ^a   Aquila, Saveria ^a   Panza, Salvatore ^a   Rizza, Pietro ^a   Lanzino, Marilena ^a   Andò, Sebastiano ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Oct 1; T3; Thyroid cancer; Thyroid hormone receptor 1

Indexed keywords

CYCLIN D1; LIOTHYRONINE; MITOGENIC AGENT; OCTAMER TRANSCRIPTION FACTOR 1; THYROID HORMONE RECEPTOR BETA;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SILENCING; HORMONE ACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; THYROID CARCINOMA; TRANSACTIVATION; UPREGULATION;

CYCD1; CYCLIN D1; OCT-1; OCTAMER-TRANSCRIPTION FACTOR-1; T3; TH; THYROID CANCER; THYROID HORMONE; THYROID HORMONE RECEPTOR Β1; THYROID HORMONE RECEPTORS; TRS; TRΒ1;

CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; OCTAMER TRANSCRIPTION FACTOR-1; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; THYROID HORMONE RECEPTORS BETA; THYROID NEOPLASMS; TRIIODOTHYRONINE; UP-REGULATION;

EID: 84886259867     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.10.001     Document Type: Article

References (46)

1. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Research 1991, 19:2499.
2. Balta A.Z., Filiz A.I., Kurt Y., Sucullu I., Yucel E., Akin M.L. Prognostic value of oncoprotein expressions in thyroid papillary carcinoma. Medical Oncology 2012, 29:734-741.
3. Basolo F., Giannini R., Toniolo A., Casalone R., Nikiforova M., Pacini F., Elisei R., Miccoli P., Berti P., Faviana P., Fiore L., Monaco C., Pierantoni M.G., Fedele M., Nikiforov Y.E., Santoro M., Fusco A. Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement. International Journal of Cancer 2002, 97:608-614.
4. Bassett J.H., Harvey C.B., William G.R. Mechanisms of thyroid hormone receptor-special nuclear and extra nuclear actions. Molecular and Cellular Endocrinology 2003, 213:1-11.
5. Boulon S., Dantonel J.C., Binet V., Vié A., Blanchard J.M., Hipskind R.A., Philips A. Oct-1 potentiates CREB.driven cyclin D1 promoter activation via a phosphor-CREB and CREB binding protein-independent mechanism. Molecular and Cellular Biology 2002, 22:7769-7779.
6. Brockman J.L., Shuler L.A. Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter. Molecular and Cellular Endocrinology 2005, 239:45-53.
7. Cao X., Kambe F., Moeller L.C., Refetoff S., Seo H. Thyroid hormone induces rapid activation of Akt/protein Kinase B-mammalian target of rapamycin-p70S6K cascade trough phosphatidylinositol 3-Kinase in human fibroblast. Molecular Endocrinology 2005, 19:102-112.
8. Chen S.T., Shieh H.Y., Lin J.D., Chang K.S., Lin K.H. Overexpression of thyroid hormone receptor beta1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line. The Journal of Endocrinology 2000, 165:379-389.
9. Davis F.B., Tang H.Y., Shih A., Keating T., Lansing L., Hercbergs A., Fenstermaker R.A., Mousa A., Mousa S.A., Davis P.J., Lin H.Y. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Research 2006, 66:7270-7275.
10. Davis P.J., Leonard J., Davis F.B. Mechanisms of non-genomic actions of thyroid hormone. Frontiers in Neuroendocrinology 2007, 29:211-218.
11. Davis P.J., Davis F.B., Lin H.Y. Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors. Steroids 2008, 73:1013-1017.
12. Degrassi A., Monaco M.C., Lisignoli G., Belvedere O., Oneguzzi S., Malangone W., Bonora M.L., Piacentini A., Lavaroni S., Scarbolo M., Ambesi-Impiombato F.S., Facchini A. Cell cycle synchronization of FRTL5 cells. A physiological model system. Journal of Experimental and Clinical Cancer Research 1998, 17:527-532.
13. Eric A., Klein E.A., Assoian R.K. Transcriptional regulation of the cyclin D1 gene at a glance. Journal of Cell Science 2008, 121:3853-3857.
14. Hall L.C., Salazar E.P., Staci R., Liu N. Effects of thyroid hormones on human breast cancer cell proliferation. Journal of Steroid Biochemistry and Molecular Biology 2008, 109:57-66.
15. Hernandez G.B., Park K.S., Zhan Q., Cheng S.Y. Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity. Endocrinology 1999, 140:5267-5274.
16. Hiroi Y., Kim H.H., Ying H., Furuya F., Huang Z.H., Simoncini T., Noma K., Ueki K., Nguyen N.H., Scanlan T.S., Moskowitz M.A., Cheng S.Y., Liao J.K. Rapid non-genomic actions of thyroid hormone. Proceeding of the National Academy of Sciences 2006, 103:14104-14109.
17. Hsieh M.L., Juang H.H. Cell growth effects of triiodothyronine and expression of thyroid hormone receptor in prostate carcinoma cells. Journal of Andrology 2005, 26:422-428.
18. Kakizawa T., Miyamoto T., Ichikawa K., Kanedo A., Suzuki S., Hara M., Nagasawa T., Takeda T., Mori J., Kumagai M., Hashizume K. Functional interaction between Oct-1 and Retinoid X receptor. The Journal of Biological Chemistry 1999, 27:19103-19108.
19. Kakizawa T., Miyamoto T., Ichikawa K., Takeda T., Susuki S., Mori J., Kumagai M., Yamashita K., Hashizume K. Silencing mediator for retinoid and thyroid hormone receptors interacts with octamer transcription factor-1 and acts as a transcriptional repressor. Journal of Biological Chemistry 2001, 30:9720-9725.
20. Kenessey A., Ojamaa K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. The Journal of Biological Chemistry 2006, 281:20666-20672.
21. Kowalik M.A., Perra A., Pibiri M., Cocco M.T., Samarut J., Plateroti M., Ledda-Columbano G.M., Columbano A. TRB is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells. Journal of Hepatology 2010, 53:686-692.
22. Lazar M.A., Chin W.W. Nuclear thyroid hormone receptors. Journal Clinical Investigation 1990, 86:1777-1782.
23. Lin H.Y., Sun M., Tang H.Y., Lin C., Luidens M.K., Mousa S.A., Incerpi S., Drusano G.L., Davis F.B., Davis P.J. L-thyroxine vs 3,5,3'-triiodo-L-thyroxne and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol3-kinase. American Journal of Physiology Cell Physiology 2009, 295:980-991.
24. Lin H.Y., Tang H.Y., Shih A., Keating T., Cao G., Davis P.J., Davis F.B. Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. Steroids 2006, 72:180-187.
25. Magné S., Caron S., Charon M., Rouyez M.C., Dusanter-Fourt I. STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. Molecular and Cellular Biology 2003, 24:8934-8945.
26. Meireles A.M., Preto A., Rocha A.S., Rebocho A.P., Máximo V., Pereira-Castro I., Moreira S., Feijão T., Botelho T., Marques R., Trovisco V., Cirnes L., Alves C., Velho S., Soares P., Sobrinho-Simões M. Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid 2007, 17:707-715.
27. Mirfakhraee S., Mathews D., Peng L., Woodruff S., Zigman J.M. A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature. Thyroid Res. 2013, 4;6(1):7.
28. Moeller L.C., Cao X., Dumitrescu A.M., Seo H., Refetoff S. Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor B through the phosphatidylinositol 3-kinase pathway. Nuclear Receptor Signaling 2006, 4:1-4.
29. Nucera C., Lawler J., Hodin R., Parangi S. The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?. Oncotarget 2010, 1:751-756.
30. Oetting A., Yen P.M. New insights into thyroid hormone action. Best Practice and Research Clinical Endocrinology and Metabolism 2007, 21:193-208.
31. Perez-Juste G., Aranda A. The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation. Journal of Biological Chemistry 1999, 274:5026-5031.
32. Pibiri M., Ledda-Columbano G.M., Cossu C., Simbula G., Menegazzi M., Columbano A. Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). Federation of American Societies for Experimental Biology 2001, 15:1006-1013.
33. Poplawski P., Nauman A. Thyroid hormone -triiodothyronine- has contrary effect on proliferation of human proximal tubules cell line (HK2) and renal cancer cell lines (caki2, Caki1) - role of E2F4, E2F5 and p107, p130. Thyroid Research 2008, 13:1-5.
34. Porlan E., Vidaurre O.G., Rodríguez-Peña A. Thyroid hormone receptor-beta (TR beta1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2. Oncogene 2008, 27:2795-2800.
35. Prefontaine G.G., Lemieux M.E., Giffin W., Shild-Poulter C., Pope L., LaCasse E., Walker P., Hache R. Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. Molecular and Cellular Biology 1998, 18:3416-3430.
36. Sirianni R., Chimento A., Malivindi R., Mazzitelli I., Andò S., Pezzi V. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation. Cancer Research 2007, 67:8368-8377.
37. Storey N.M., Gentile S., Ullah H., Russo A., Muessel M., Erxleben C., Armstrong D.L. Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proceedings of the National Academy Sciences 2006, 103:5197-5201.
38. Takahashi-Yanaga F., Sasaguri T. GSK-3β regulates cyclin D1 expression: a new target for chemiotherapy. Cell Signaling 2008, 20:581-589.
39. Tang H.Y., Lin H.Y., Zhang J., Davis P.J., Davis F.B. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 2004, 145:3265-3272.
40. Verga Falzacappa C., Mangialardo C., Patriarca V., Bucci B., Amendola D., Raffa S., Torrisi M.R., Silvestrini G., Ballanti P., Moriggi G., Stigliano A., Brunetti E., Toscano V., Misiti S. Thyroid hormone induce cell proliferation and survival in ovarian granulosa cells COV434. Journal of Cellular Physiology 2009, 221:242-253.
41. Verga Falzacappa C., Patriarca V., Bucci B., Mangialardo C., Michienzi S., Moriggi G., Stigliano A., Brunetti E., Toscano V., Misiti S. The TRB1 is essential in mediating T3 action on Akt pathway in human pancreatic insulinoma cells. Journal of Cellular Biochemistry 2009, 106:835-848.
42. Verga Falzacappa C., Petrucci E., Patriarca V., Michienzi S., Stigliano A., Brunetti E., Toscano V., Misiti S. Thyroid hormone receptor TRB1 mediates Akt activation by T3 in pancreatic B cells. Journal of Molecular Endocrinology 2007, 38:221-233.
43. Voz M.L., Peers B., Wiedig M.J., Jacquemin P., Belayew A., Martial J.A. Transcriptional regulation by triiodothyronine requires synergistic action of the thyroid receptor with another trans-acting factor. Molecular Cell Biology 1992, 12:3991-3997.
44. Wang S., Lloyd R.V., Hutzler M.J., Safran M.S., Patwardhan N.A., Khan A. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Modern Pathology 2000, 13:882-887.
45. Weiss R.E., Ramos H.E. Thyroid hormone receptor subtypes and their interaction with steroid receptor coactivators. Vitamins and Hormones 2004, 68:185-207.
46. Yeh N.C., Chou C.W., Weng S.F., Yang C.Y., Yen F.C., Lee S.Y., Wang J.J., Tien K.J. Hyperthyroidism and thyroid cancer risk: a population-based cohort study. Expert Clinical Endocrinology Diabetes 2013, 121:402-406.